邹雯雯, 姚国荣. 减少阴道镜过度转诊的分子策略:宫颈癌筛查基因甲基化检测的研究进展. 2026. biomedRxiv.202611.00023
减少阴道镜过度转诊的分子策略:宫颈癌筛查基因甲基化检测的研究进展
通讯作者: 姚国荣, 110790470@qq.com
DOI:10.12201/bmr.202611.00023
Translating DNA Methylation Biomarkers into Practice: Precision Strategies to Reduce Colposcopy Referrals in Cervical Screening
Corresponding author: yaoguorong, 110790470@qq.com
-
摘要:宫颈癌筛查中HPV检测与液基细胞学检查(thin-prep cytology test, TCT)的高敏感性导致阴道镜转诊率居高不下,造成医疗资源浪费与患者心理负担。DNA甲基化作为表观遗传标志物,通过靶向宿主基因(如PAX1、SOX1、JAM3)的异常甲基化事件,可精准识别高危型人乳头状瘤病毒(high‐risk human papillomavirus,hrHPV)持续感染向宫颈上皮内瘤变2级及以上(CIN2+)的进展风险,显著提升筛查特异性。本文系统综述宫颈癌流行病学数据,剖析现行指南对CIN2+管理的局限性,聚焦DNA甲基化检测的临床应用,本文旨在为优化宫颈癌筛查策略提供理论依据,推动甲基化技术从实验室向临床的转化。
Abstract: In cervical cancer screening, the high sensitivity of HPV testing and liquid-based cytology (thin-prep cytology test, TCT) leads to persistently elevated referral rates for colposcopy, resulting in medical resource waste and psychological burden on patients. DNA methylation, as an epigenetic biomarker, can precisely identify the progression risk of persistent high-risk human papillomavirus (hrHPV) infection to cervical intraepithelial neoplasia grade 2 or higher (CIN2+) by targeting abnormal methylation events in host genes (e.g.,SPAX1,SSOX1,SJAM3), thereby significantly improving screening specificity. This article systematically reviews epidemiological data on cervical cancer, analyzes the limitations of current guidelines in managing CIN2+, and focuses on the clinical applications of DNA methylation testing. The review aims to provide a theoretical foundation for optimizing cervical cancer screening strategies and to advance the translation of methylation-based technologies from laboratory research to clinical practice.
Key words: Persistent; high-risk; human papillomavirus (hrHPV) infection,Cervical; high-grade; squamous intraepithelial; lesion (CIN2+),DNA; methylation testing,Colposcopy; referral rate,Epigenetic; biomarkers提交时间:2026-11-16
版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。 -
图表
-
赵丽媛, 陈志芳. PAX1甲基化在宫颈癌中诊断及分流作用的研究进展. 2024. doi: 10.12201/bmr.202412.00067
罗燕艳, 代新珍, 廖燕婷, 罗小婉, 符丽华. HPV L1壳蛋白及p16蛋白在高危型HPV持续感染的宫颈低级别鳞状上皮内病变患者临床转归中的意义. 2024. doi: 10.12201/bmr.202410.00056
李美, 楼姣英. 清毒栓对高危型HR-HPV持续感染的疗效和机制研究. 2024. doi: 10.12201/bmr.202412.00028
王子文, 沈洲姬▲, 郭菲. DNA甲基化和组蛋白修饰在糖尿病肾病中的研究进展. 2024. doi: 10.12201/bmr.202407.00011
蔡小继, 车璇. 经阴道子宫切除术治疗绝经后非脱垂高级别宫颈病变的可行性和安全性. 2025. doi: 10.12201/bmr.202501.00068
蔡小继. 浙江嘉兴地区女性高危型人乳头瘤病毒亚型的分布情况及高危因素的分析. 2025. doi: 10.12201/bmr.202502.00011
贺明敏, 汪玲莉. 基于“伏邪”理论探讨高危型HPV持续性感染的病因病机和防治思路. 2025. doi: 10.12201/bmr.202510.00027
陈惠怡, 路明, 钟培松, 任洪磊, 殷方兰▲. 肝癌早期筛查的精准化研究进展. 2025. doi: 10.12201/bmr.202512.00013
龙棹然, 常淑芳. 女性肛门生殖器多灶性上皮内瘤变的高危因素与治疗策略研究进展. 2026. doi: 10.12201/bmr.202604.00140
吴稚晖, 刘红, 周晓雨, 张茜, 谭年喜. RUNX3、P16和DAPK基因启动子DNA甲基化与非小细胞肺癌化疗敏感性的关系. 2025. doi: 10.12201/bmr.202510.00045
-
序号 提交日期 编号 操作 1 2026-10-27 10.12201/bmr.202611.00023V1
下载 -
-
公开评论 匿名评论 仅发给作者
引用格式
访问统计
- 阅读量:9
- 下载量: 0
- 评论数:0

登录
注册




京公网安备